Inverse relationship of cannabimimetic (R+)WIN 55, 212 on behavior and seizure threshold during the juvenile period

Pharmacology Biochemistry and Behavior

Volumn 100, Issue 3, 2012, Pages 474-484

  Rudenko, V ^a   Rafiuddin, A ^a   Leheste, J R ^a   Friedman, L K ^a  

^a NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Anticonvulsant; Cannabinoids; CB1 receptor; Development; Epilepsy; Hippocampus; Psychotropic

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; KAINIC ACID;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALANCE IMPAIRMENT; BEHAVIOR DISORDER; BRAIN INJURY; CONTROLLED STUDY; DRUG DOSE COMPARISON; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; HIPPOCAMPAL INJURY; IMMOBILIZATION; IMMUNOHISTOCHEMISTRY; MALE; MUSCULOSKELETAL STIFFNESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCORING SYSTEM;

AGING; ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; BENZOXAZINES; CANNABINOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; HIPPOCAMPUS; KAINIC ACID; MALE; MORPHOLINES; NAPHTHALENES; NERVE TISSUE PROTEINS; NEURONS; NEUROTOXICITY SYNDROMES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; SEIZURES; SEVERITY OF ILLNESS INDEX; STATUS EPILEPTICUS;

RATTUS;

EID: 80155182048     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.10.005     Document Type: Article

References (73)

1. B.J. Albala, S.L. Moshe, and R. Okada Kainic acid-induced seizures: a developmental study Dev Brain Res 13 1984 139 148 (Pubitemid 14128004)
2. M.B. Amar Cannabinoids in medicine: a review of their therapeutic potential J Ethnopharmacology 105 2006 1 25
3. A. Ameri, and T. Simmet Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices Arch Pharmacol 361 2000 265 272 (Pubitemid 30106337)
4. 9 tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage Behav Brain Res 220 2011 194 201
5. J. Avallone, E. Gashi, B. Magrys, and L.K. Friedman Distinct regulation of metabotropic glutamate receptor (mGluR1 alpha) in the developing limbic system following multiple early-life seizures Exp Neurol 202 2006 100 111 (Pubitemid 44344252)
6. R.E. Blair, L.S. Deshpande, S. Sombati, K.W. Falenski, B.R. Martin, and R.J. DeLorenzo Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus J Pharmacol Exp Ther 317 2006 1072 1078 (Pubitemid 43764110)
7. M.G. Bossong, and R.J.M. Niesink Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia Progressin Neurobiology 92 2010 370 385
8. 9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabiniod receptors and cannabinoid receptor-activated G proteins in rat brain J Neurochem 73 1999 2447 2459
9. G.C. Chan, T.R. Hinds, S. Impey, and D.R. Storm Hippocampal neurotoxicity of Delta 9-hydrocannabinol J Neurosci 18 1998 5322 5332
10. P. Consroe Brain cannabinoid systems as targets for the therapy of neurological disorders Neurobiol Dis 5 1998 534 551 (Pubitemid 29075849)
11. L.S. Deshpande, R.E. Blair, J.M. Ziobro, S. Sombati, B.R. Martin, and R.J. DeLorenzo Endocannabinoids block status epilepticus in cultured hippocampal neurons Eur J Pharmacol 558 2006 52 59
12. L.S. Deshpande, S. Sombati, R.E. Blair, D.S. Carter, B.R. Martin, and R.J. DeLorenzo Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy Neurosci Lett 411 2007 11 16 (Pubitemid 44751939)
13. A. El Manira, and A. Kyriakatos The role of endocannabinoid signaling in motor control Physiology 25 2010 2230 2238 Review
14. K.W. Falenski, R.E. Blair, L.J. Sim-Selley, B.R. Martin, and R.J. DeLorenzo Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy Neuroscience 146 2007 1232 1244 (Pubitemid 46694119)
15. K.W. Falenski, D.S. Carter, A.J. Harrison, B.R. Martin, R.E. Blair, and R.J. DeLorenzo Temporal characterizaton of changes in hippocampal cannabinoid CB1 receptor expression following pilocarpine-induced status epilepticus Brain Res 1262 2009 64 72
16. L. Ferraro, M.C. Tomasini, S. Beggiato, S. Gaetani, T. Cassano, and V. Cuomo Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions J Neural Transm 116 2009 1017 1027
17. T.F. Freund, I. Katona, and D. Piomelli Role of endogenous cannabinoids in synaptic signaling Physiol Rev 83 2003 1017 1066 (Pubitemid 36828930)
18. P.A. Fried Marihuana use by pregnant women and effects on offspring: an update Neurobehav Toxicol Teratol 4 1982 451 454 (Pubitemid 12023275)
19. L.K. Friedman Calcium: a role for neuroprotection and sustained adaptation Mol Interv 6 2006 315 329 (Pubitemid 46046942)
20. L.K. Friedman, and J. Velísková GluR2 hippocampal knockdown reveals developmental regulation of epileptogenicity and neurodegeneration Brain Res Mol Brain Res 61 1998 224 231 (Pubitemid 28511368)
21. L.K. Friedman, J. Avallone, B. Magrys, and H. Liu Age-dependent effects of seizures on AMPA receptor Dev Neurosci 29 2007 427 437
22. F. Grotenhermen Cannabinoids Curr Drug Targets CNS Neurol Disord 4 2005 507 530 (Pubitemid 41448378)
23. S. Haj-Dahmane, and R.Y. Shen Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 receptors J Pharmacol Exp Ther 33 2009 186 196
24. A.J. Hampson, J. Axelrod, and M. Grimaldi Cannabinoids as antioxidants and neuroprotectants U.S. Patent 6,630,507 B1 2003 7 Oct.
25. H.H. Hansen, B. Krutz, M. Sifringer, V. Stefovska, P. Bittigau, and F. Pragst Cannabinoids enhance susceptibility of immature brain to ethanol neurotoxicity Ann Neurol 64 2008 42 52
26. T. Harkany, M. Guzmán, I. Galve-Roperh, P. Berghuis, L.A. Devi, and K. Mackie The emerging functions of endocannabinoid signaling during CNS development Trends Pharmacol Sci 28 2007 83 92 (Pubitemid 46161836)
27. Z. Hegyi, G. Kis, K. Holló, C. Ledent, and M. Antal Neuronal and glial localization of the cannabinoid-1 receptor in the superficial spinal dorsal horn of the rodent spinal cord Eur J Neurosci 30 2 2009 251 262 Jul
28. M. Herkenham, A.B. Lynn, M.D. Little, M.R. Hohnson, L.S. Melvin, and B.R. De Costa Cannabinoid receptor localization in brain Proc Natl Acad Sci U S A 1990 1932 1936
29. A.F. Hoffman, and C.R. Lupica Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus J Neurosci 20 2000 2470 2479 (Pubitemid 30220334)
30. G.L. Holmes, and J.L. Thompson Effects of kainic acid on seizure susceptibility in the developing brain Dev Brain Res 39 1988 51 59 (Pubitemid 18065834)
31. M. Kang-Park, W.A. Wilson, C.M. Kuhn, S.D. Moore, and H.S. Swartzwelder Differential sensitivity of GABAA receptor-mediated IPScs to cannabinoids in hippocampal slices from adolescent and adult rats J Neurophysiol 98 2007 1223 1230 (Pubitemid 47435876)
32. J. Kaur, B. Magrys, H. Liu, and L.K. Friedman NR1 knockdown reduces seizure activity during a period of high seizure susceptibility Neuromolecular Med 9 2007 298 314 (Pubitemid 350242633)
33. T. Kirschstein, M. Bauer, L. Müller, C. Rüschenschmidt, M. Reitze, and A.J. Becker Loss of metabotropic glutamate receptor-dependent long-term depression via downregulation of mGluR5 after status epilepticus J Neurosci 27 2007 7696 7704 (Pubitemid 47093822)
34. A. Köfalvi, R.J. Rodrigues, C. Ledent, K. Mackie, E.S. Vizi, R.A. Cunha, and B. Sperlágh Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis J Neurosci 25 2005 2874 2884 (Pubitemid 40389245)
35. H.B. Laurén, F.R. Lopez-Picon, A.M. Brandt, C.J. Rios-Rojas, and I.E. Holopainen Transcriptome analysis of the hippocampal CA1 pyramidal cell region after kainic acid induced status epilepticus in juvenile rats PLoS One 5 2010 e10733
36. J. Lawston, A. Borella, J.K. Robinson, and P.M. Whitaker-Azmitia Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2 Brain Res 877 2000 407 410
37. 9-Tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism Psychopharmacol 126 1996 125 131 (Pubitemid 26246762)
38. H. Liu, L.K. Friedman, and J. Kaur Perinatal seizures preferentially protect CA1 neurons from seizure-induced damage in prepubescent rats Seizure 15 2006 1 16 (Pubitemid 43092089)
39. 9-tetrahydrocannabivirin modulates inhibitory neurotransmission in the cerebellum British J Phramacol. 154 2008 204 215 (Pubitemid 351620396)
40. K. Mackie Distribution of cannabinoid receptors in the central and peripheral nervous system Handb Exp Pharmacol 168 2005 299 325
41. P. Mailleux, and J.J. Vanderhaeghen Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons Neurosci Lett 148 1992 173 176 (Pubitemid 23007732)
42. G. Marsicano, S. Goodenough, K. Monory, H. Hermann, M. Eder, and A. Cannich CB1 cannabinoid receptors and on-demand defense against excitotoxicity Science 302 2003 84 88 (Pubitemid 37210691)
43. T. Nagayama, A.D. Sinor, R.P. Simon, J. Chen, S.H. Graham, and K. Jin Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures J Neurosci 19 1999 2987 2995 (Pubitemid 29173995)
44. B. Nickel, and I. Szelenyi Comparison of changes in the EEG of freely moving rats induced by enciprazine, buspirone and diazepam Neuropharmacology 28 1989 799 803 (Pubitemid 19209210)
45. L. Nitecka, E. Tremblay, G. Charton, J.P. Bouillot, M.L. Berger, and Y. Ben-Ari Maturation of kainic acid seizure-brain damage syndrome in the rat. II. Histopathological sequelae Neuroscience 13 1984 1073 1094 (Pubitemid 15198961)
46. T. Ohno-Shosaku, T. Maejima, and M. Kano Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals Neuron 29 2001 729 738 (Pubitemid 32323945)
47. T. Ohno-Shosaku, J. Shosaku, H. Tsubokawa, and M. Kano Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation Eur J Neurosci 15 2002 953 961 (Pubitemid 35463629)
48. M. O'Shea, M.E. Singh, I.S. McGregor, and P.E. Mallet Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats J Psychopharmacol 18 2004 502 508 (Pubitemid 39665118)
49. 2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity Brain 132 2009 3152 3164
50. T. Pattij, J. Wiskerke, and A.N.M. Schoffelmeer Cannabiniod modulation of executive functions Eur J Pharm 585 2008 458 463
51. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 2nd ed. 1986 Academic Press Sydney
52. M. Ranganathan, and D.C. D'Souza The acute effects of cannabinoids on memory in humans: a review Psychopharmacology 188 2006 425 444 (Pubitemid 44498214)
53. J. Romero, E. Garcia-Palomero, J.G. Castro, L. Garcia-Gil, J.A. Ramos, and J.J. Fernandez-Ruiz Effects of chronic exposure to delta9- tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions Brain Res Mol Brain Res 46 1997 100 108 (Pubitemid 27214360)
54. R. Sankar, D. Shin, A.M. Mazarati, H. Liu, and C.G. Wasterlain Ontogeny of self-sustaining status epilepticus Dev Neurosci 21 1999 345 351
55. M.R. Sarkisian, P. Tandon, Z. Liu, Y. Yang, A. Hori, and G.L. Holmes Multiple kainic acid seizures in the immature and adult brain: ictal manifestations and long term effects on learning and memory Epilepsia 38 1997 1157 1166 (Pubitemid 27481413)
56. A. Scallet Neurotoxicology of cannabis and THC: a review of chronic exposure studies in animals Pharmacol Biochem Behav 40 1991 671 676
57. M.S. Scher, G.A. Richardson, P.A. Coble, N.L. Day, and D.S. Stoffer The effects of prenatal alcohol and marijuana exposure: disturbances in neonatal sleep cycling and arousal Pediatr Res 24 1988 101 105
58. M. Schneider, E. Schömig, and F.M. Leweke Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats Addict Biol 13 2008 345 357
59. S. Schuchmann, D. Schmitz, C. Rivera, S. Vanhatalo, B. Salmen, K. Mackie, J. Voipio, and K. Kaila Changes of neuronal activity in areas CA1 and CA3 during anoxia and normoxic or hyperoxic reoxygenation in juvenile rat organotypic hippocampal slice cultures Nat Med 12 2006 817 823
60. A. Sheinin, G. Talani, M. Davis, and D. Lovinger Endocannabinoid and mGluR5-dependent shrt-term synaptic depression in an isolated neuron.bouton preparation from hippocampal CA1 region J Neurophysiol 100 2008 1041 1052
61. M. Shen, and S.A. Thayer Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture Mol Pharmacol 55 1999 8 13 (Pubitemid 29042516)
62. M. Shen, T.M. Piser, V.S. Seybold, and S.A. Thayer Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures J Neurosci 16 1996 4322 4334 (Pubitemid 26243028)
63. P. Tagliaferro, A.J. Ramos, E.S. Onaivi, S.G. Evrard, M.D. Vega, and A. Brusco Morphometric study on cytoskeletal components of neuronal and astroglial cells after chronic CB1 agonist treatment Methods Mol Med 123 2006 91 104
64. K. Tsou, S. Brown, M.C. Sañudo-Peña, K. Mackie, and J.M. Walker Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system Neuroscience 83 1998 393 411 (Pubitemid 28062631)
65. M. Van der Stelt, and V. Di Marzo Cannabinoid receptors and their role in neuroprotection Neuromolecular Med 7 2005 37 50 Review. (Pubitemid 41278188)
66. M.D. Van Sickle, M. Duncan, P.J. Kingsley, A. Mouihate, P. Urbani, and K. Mackie Identification and functional characterization of brainstem cannabinoid CB2 receptors Science 310 2005 329 332 (Pubitemid 41457202)
67. W.B. Veldhuis, M. van der Stelt, M.W. Wadman, G. van Zadelhoff, M. Maccarrone, F. Fezza, G.A. Veldink, J.F. Vliegenthart, P.R. Bär, K. Nicolay, and V. Di Marzo Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases J Neurosci 23 2003 4127 4133 (Pubitemid 36958432)
68. M.J. Wallace, J.L. Wiley, B.R. Martin, and R.J. DeLorenzo Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects Eur J Pharmacol 428 2001 51 57 (Pubitemid 32971757)
69. M.J. Wallace, B.R. Martin, and R.J. DeLorenzo Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity Eur J Pharmacol 452 2002 295 301 (Pubitemid 35279432)
70. M.J. Wallace, R.E. Blair, K.W. Falenski, B.R. Martin, and R.J. DeLorenzo The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy J Pharmacol Exp Ther 307 2003 129 137 (Pubitemid 37151898)
71. X. Wang, J.G. Horswill, B.J. Whalley, and G.J. Stephens Effects of the allosteric antagonist 1-(4-chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl) phenyl]urea (PSNCBAM-1) on CB1 receptor modulation in the cerebellum Mol Pharmacol 79 2011 758 767
72. N. Wettschureck, M. van der Stelt, H. Tsubokawa, H. Krestel, A. Moers, and S. Petrosino Forebrain-specific inactivation of Gq/G11 family G proteins results in age-dependent epilepsy and impaired endocannabinoid formation Mol Cell Biol 26 2006 5888 5894 (Pubitemid 44134342)
73. M.R. Zarrindast, M. Nasehi, M. Piri, and P. Bina Anxiety-like behavior induced by histaminergic agents can be prevented by cannabiniodergic WIN55,212-2 injected into the dorsal hippocampus in mice Pharmacol Biochem Behav 94 2009 387 396